Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    Open Studies | "Coxsackievirus Infections"
Show Display Options
Rank Status Study
1 Recruiting Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Ipilimumab
2 Recruiting Phase I Study of Intratumoral CAVATAK™ and Pembrolizumab in Subjects With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: CAVATAK;   Drug: Pembrolizumab
3 Recruiting Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200)
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21
4 Not yet recruiting Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
Condition: Hand Foot and Mouth Disease
Interventions: Biological: the first batch vaccine;   Biological: the second batch vaccine;   Biological: the third batch vaccine
5 Recruiting Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth Disease
Interventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid;   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.